Delivery Order SPE2DB20D2002-SPE2DB21FL54D
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,705.35 firm fixed-price delivery order is for the supply of 120 tablets of the pharmaceutical product Lialda DR 1.2 GM. The contract has an ultimate completion date of August 16, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
- This federal contract award, with ID SPE2DX15D6028, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $97,264.05 firm fixed-price delivery order is for 4534482086 units of LIALDA 1.2GM 1440S, a pharmaceutical product. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans'...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,420.36 to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA DR, to be delivered from its Conshohocken, Pennsylvania facility by August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring and providing medical supplies to support the...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,333.48 firm-fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The federal contract award described is for the delivery of pharmaceutical and medical products to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price valued at $14,941.43 and has a completion date of November 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $16,089.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,898.44, is a delivery order under the company's Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999 to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves as the primary vehicle for...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order under an Indefinite Delivery Contract (IDC) valued at $1,289.73. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment...
- This federal contract award is for the delivery of pharmaceutical products, including various medications and medical supplies, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $22,870.92. The contract is a delivery order with a firm fixed price pricing type. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,281.84 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB21FL54DDelivery Order
This federal contract award is for the delivery of pharmaceutical products, specifically the drug Lialda, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price of $1,058.76 and a completion date of August 23, 2021. The contract was awarded on August 20, 2021, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/20/21 |